期刊文献+

改善蛋白质药物PELA控释微球释放性能的研究 被引量:4

Study on Improvement of Release Behavior of Protein Drugs from PELA Microspheres
下载PDF
导出
摘要 开展了以乙酸乙酯(EA)与二氯甲烷(MC)的混合溶液为有机溶剂、以单甲氧基聚乙二醇-聚-DL-乳酸(PELA)为膜材的W/O/W复乳-分步固化法制备蛋白质药物控释微球的研究。为解决微球突释率高、且突释后的释药速度缓慢的问题,实现后期快速释放,以溶菌酶为模型蛋白,重点考察了膜材组成、内水相体积以及外水相盐浓度对微球释药速率的影响。结果表明,当外水相盐浓度增大至1.5%时可将释放率由22%提升至45%,是一种较好的加快微球释药速率的途径,因此可通过选择适当的外水相盐浓度,达到所期望的药物释药速率。 The microspheres for protein controlled release were prepared by W/O/W double emulsion-stepwise solidification method. Monomethoxypoly (ethylene glycol)-b-poly-DL-lactide (PELA) was used as the wall material, with ethyl acetate(EA) as organic solvent of oil phase,and lysozyme as model protein. In order to increase the release rate after the burst release, the effects of polymer composition, the volume of internal aqueous phase and the concentration of NaCl in external aqueous phase were investigated. It showed that the NaCl concentration in external aqueous phase affected the release rate apparently. It was found that when the concentration of NaCl increased from 0.9% to 1.5 % , the release rate increased from 22 % to 45 % after 40 days of release study. Therefore the desired protein release profile could be achieved by selecting suitable concentration of NaCl in external aqueous phase.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2005年第2期25-30,共6页 China Biotechnology
基金 国家杰出青年科学基金资助项目(20125616)
关键词 微球 释药速率 突释 控释 蛋白质药物 聚-DL-乳酸 复乳 释放性能 水相 W/O Controlled release microspheres W/O/W double emulsion Rapid release
  • 相关文献

参考文献14

  • 1陈建海,陈志良,侯连兵,胡育筑.以PHBV/PLA为载体的地西泮缓释微球体外释放度的研究[J].中国药科大学学报,2000,31(1):11-14. 被引量:9
  • 2王继麟,苏焱,朱家鸿,曾令冰.包裹破伤风类毒素蛋白的聚乳酸及聚乳酸/聚乙醇酸共聚微球的制备和体外释放特性[J].中国药学杂志,2001,36(5):318-322. 被引量:10
  • 3邱伟,孟凡涛,马光辉,苏志国.复乳法制备红细胞代用品[J].生物化学与生物物理学报,2003,35(5):467-472. 被引量:4
  • 4Bartus R T, Tracy M A, Emerich D F, et al. Sustained delivery of proteins for novel therapeutic products. Science, 1998,281:1161 ~1162
  • 5Burgess D J, Hickey A J. Microsphere technology and applications. In: Swarbrick J, Boylan J C, eds. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, 1994.1 ~29
  • 6Pavanetto F, Conti B, Genta I, et al. Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation.Int J Pharm, 1992,84:151 ~ 159
  • 7Bodmeier R, Wang H, Dixon D J, et al. Polymeric microspheres prepared by spraying into compressed carbon dioxide. Pharm Res,1995,12(8) :1211 ~ 1217
  • 8Chouinid F, Buczkowski S, Lenaerts V. Poly(alkyl-cyanoacrylate)nanocapsules: physicochemical characterization and mechanism of formation. Pharrm Res, 1994,11 (6): 869 ~ 874
  • 9Ogawa Y, Yamamoto M, Okada H, et al. A new technique of efficiently entrapped leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull,1988,36:1095~ 1103
  • 10Meng F T, Ma G H, Qiu W, et al. W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristcs of microparticles. J Contr Rel,2003,91:407~ 416

二级参考文献34

  • 1Haeckel S,Preceedings of the second world meeting,1998年,196页
  • 2Singh M,Vaccine,1997年,15卷,5期,475页
  • 3Cheng A,J Pharm Sci,1996年,85卷,2期,129页
  • 4Chang TMS. Blood Substitutes: Principles, Methods, Products and Clinical Trials, Basel: Karger Landes Systems, 1998
  • 5Hong M, Cai J, Meng WF, Li SY, Yuan ZY. PEG and DBBF modified porcine hemoglobin and their oxygen-carrying capacity. Acta Biochim Biophys Sin, 2002, 34(4): 452 -456
  • 6Winslow RM Blood substitutes. Adv Drug Deliv Rev, 2000, 40(3): 131 -142
  • 7Mottedini R. Interaction of hemoglobin with nitric oxide and carbon monoxide: Physiological implication, In: Winslow RM,Vandegriff KD, Intaglietta M eds. Blood substitutes: New Challenges, Boston: Birkhauser, 1995, 74 - 98
  • 8Tomoda A, Murakami E, Shibuya T. Production of nitric oxide (NO) during the oxidation of human oxyhemogiobin by nitrite:Application of a NO-selective electrod for the measurement of NO. Artff Cells Blood Substit Immobil Biotechnol, 1997, 25(6):501 - 509
  • 9Yu WP, Chang TM. Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: A preliminary report. Artif Cells Blood Substit Immobil Biotechnol, 1994, 22(3): 889 -893
  • 10Yu WP, Chang TM. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: Preparation and characterization. Artif Cells Blood Substit Immobil Biotechnol: 1996, 24(3), 169 - 183

共引文献20

同被引文献71

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部